The Intellectual Property Owners Association, IPO (there are many other things in this domain with the same acronym), is truly nasty and harmful. It not only lobbies for software patents; it lobbies for just about everything that harms science and technology for the sake of scientists and technologists being taxed by lawyers and patent trolls. IPO should be approached/treated/viewed with the same disdain the public has for front groups of oil and coal giants; even military contractors...
"IPO should be approached/treated/viewed with the same disdain the public has for front groups of oil and coal giants; even military contractors..."It hardly surprised us to learn that there was yet another stacked panel (of this litigation zealots' front group, IPO) taking place yesterday; it was promoted by Patent Docs the other day; it's a site which campaigns for software patents, patents on life, and is expectedly (given those two things) against PTAB, the Patent Trial and Appeal Board whose inter partes reviews (IPRs) invalidate a lot of patents, soon to be reaffirmed by the Federal Circuit. There has been an attempt to disenfranchise Unified Patents (and RPX), denying them access to IPRs. Watch who debated these things yesterday:
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Federal Circuit Appeals and Remands to the PTAB: Recent Lessons and a Look Ahead" on November 8, 2018 from 2:00 to 3:00 pm (ET). Michael Flibbert of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; Sheila Kadura of Dell Technologies; and John O'Quinn of Kirkland & Ellis, LLP will review case law and discuss strategies for affirming or reversing a PTAB decision.
The UK Supreme Court has granted permission to the UK BioIndustry Association (BIA) to intervene in an ongoing life sciences dispute.
Actavis v ICOS is a patent dispute that addresses the patentability of a discovery made during the dosage regime testing stage of a clinical trial.
BIA is arguing that medical innovations should be patentable irrespective of how the invention is made.